Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)

Q: What does CUSIP 640979100 represent in this 13F holders report?

CUSIP 640979100 is the security identifier for NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2023?

60 institutional investors reported NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 640979100

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 186,788,806
Total 13F shares: 43,747,888
Share change: +7,394,721
Total reported value: $744,815,306
Put/Call ratio: 65%
Price per share: $17.05
Number of holders: 60
Value change: +$130,275,365
Number of buys: 43
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 640979100?
CUSIP 640979100 identifies NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 640979100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
AMGEN INC	3/4/5	10%+ Owner	— class O/S missing	35,368,653	$423,716,463	—	19 Sep 2023	3/4/5
SOFTBANK GROUP CORP.	13F	Company	4.1%	7,646,916	$107,897,985	—	30 Sep 2023	13F
FMR LLC	13F 3/4/5	Company · Other*	3%	5,624,353	$79,359,621	—	30 Sep 2023	13F 3/4/5
MIC Capital Management UK LLP	13F	Company	2.4%	4,460,700	$62,940,478	—	30 Sep 2023	13F
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST	13F	Company	1.8%	3,309,124	$46,691,740	—	30 Sep 2023	13F
Artal Group S.A.	13F	Company	1.5%	2,802,702	$39,546,000	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.2%	2,168,518	$29,698,638	—	30 Sep 2023	13F
EcoR1 Capital, LLC	13F	Company	1.1%	2,071,450	$29,228,160	—	30 Sep 2023	13F
Avidity Partners Management LP	13F	Company	0.96%	1,800,000	$25,398,000	—	30 Sep 2023	13F
HHLR ADVISORS, LTD.	13F	Company	0.91%	1,699,313	$23,977,306	—	30 Sep 2023	13F
ORBIMED ADVISORS LLC	13F	Company	0.8%	1,500,000	$21,165,000	—	30 Sep 2023	13F
JOHNSON & JOHNSON	13F	Company	0.49%	912,128	$12,870,126	—	30 Sep 2023	13F
SOROS CAPITAL MANAGEMENT LLC	13F	Company	0.31%	588,235	$8,299,996	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	274,748	$3,876,694	—	30 Sep 2023	13F
MARSHALL WACE, LLP	13F	Company	0.14%	256,412	$3,617,972	—	30 Sep 2023	13F
Alphabet Inc.	13F	Company	0.11%	199,608	$2,816,468	—	30 Sep 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.08%	150,000	$2,116,500	—	30 Sep 2023	13F
SCOGGIN MANAGEMENT LP	13F	Company	0.08%	150,000	$2,116,500	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	122,186	$1,724,044	—	30 Sep 2023	13F
Cormorant Asset Management, LP	13F	Company	0.05%	92,293	$1,302,256	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	73,600	$1,038,496	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.03%	58,500	$825,435	—	30 Sep 2023	13F
NORGES BANK	13F	Company	0.03%	50,000	$705,500	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	0.03%	50,000	$705,500	—	30 Sep 2023	13F
Greenland Capital Management LP	13F	Company	0.03%	47,613	$671,819	—	30 Sep 2023	13F
Middle East Fze Point72	13F	Individual	0.02%	43,713	$616,790	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	28,834	$406,848	—	30 Sep 2023	13F
FIRST TRUST ADVISORS LP	13F	Company	0.01%	26,770	$377,724	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	0.01%	25,000	$352,749	—	30 Sep 2023	13F
Laurion Capital Management LP	13F	Company	0.01%	21,557	$304,169	—	30 Sep 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.01%	21,400	$301,954	—	30 Sep 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	20,078	$283,000	—	30 Sep 2023	13F
CITIGROUP INC	13F	Company	0.01%	14,416	$203,410	—	30 Sep 2023	13F
Zimmer Partners, LP	13F	Company	0.01%	12,500	$176,375	—	30 Sep 2023	13F
Ghisallo Capital Management LLC	13F	Company	0.01%	10,000	$141,100	—	30 Sep 2023	13F
SOROS FUND MANAGEMENT LLC	13F	Company	0.01%	10,000	$141,100	—	30 Sep 2023	13F
Legal & General Group Plc	13F	Company	0.01%	10,000	$140,301	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0%	400	$5,644	—	30 Sep 2023	13F
SALEM INVESTMENT COUNSELORS INC	13F	Company	0%	100	$1,411	—	30 Sep 2023	13F

Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) as of Q4 2023

As of 31 Dec 2023, Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,747,888 shares. The largest 10 holders included SOFTBANK GROUP CORP., FMR LLC, MIC Capital Management UK LLP, ICONIQ Capital, LLC, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Artal Group S.A., EcoR1 Capital, LLC, Avidity Partners Management LP, JOHNSON & JOHNSON, and CITADEL ADVISORS LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.